| STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
|---|---|---|---|---|---|---|---|---|---|---|
| S1703-Met Breast, STM-monitoring v Usual Care | 739 | 1 | Y | 0 Screening | 489 | 70 | 40 | 13 | 1 | 0 |
| 489 | 70 | 40 | 13 | 1 | 0 | |||||
| 2 | Y | 1 Control (Usual Care) | 165 | 29 | 13 | 9 | 2 | 0 | ||
| 2 Intervention (STMDDM) | 166 | 29 | 15 | 9 | 2 | 0 | ||||
| 331 | 58 | 28 | 18 | 4 | 0 | |||||
| S1912CD-CREDIT, Fin Counseling to reduce Fin Hardship | 326 | 1 | Y | 1 Financial Navigation | 113 | 74 | 52 | 26 | 9 | 3 |
| 2 Control | 113 | 75 | 51 | 25 | 9 | 0 | ||||
| 226 | 149 | 103 | 51 | 18 | 3 | |||||
| S2108CD-Genomic Tumor Board vs Usual Practice | 1182 | 1 | Y | 1 Usual Practice | 425 | 283 | 128 | 64 | 17 | 2 |
| 2 EGTB Intervention | 523 | 415 | 183 | 80 | 19 | 3 | ||||
| 948 | 698 | 311 | 144 | 36 | 5 | |||||
| A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | ||
| 4 | 0 | 0 | 0 | 0 | 0 | |||||
| ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | ||
| 54 | 0 | 0 | 0 | 0 | 0 | |||||